Monopar Therapeutics Inc.

Q4 2024 13F Holders

Symbol
MNPR
CUSIP
61023L207
Type
Equity
Class
COM NEW
Num filings
19
Total reported value, excl. options
$57.1 M
Manager Report Date Value ($000) Shares Option Type